Comments to FDA: Probiotics Labeling Share page: Docket Number: FDA-2011-D-0376 Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics). Download Document Issues: Dietary Supplements Probiotics Other Issues Labeling Related Posts Press Releases and Statements CHPA Comments on News of Dismissals & Layoffs at FDA Feb 18, 2025 Press Releases and Statements CHPA Honors & Remembers Michael McGuffin Feb 18, 2025 Press Releases and Statements CHPA Responds to Senate Confirming RFK Jr. to Lead HHS Feb 12, 2025